Sanofi Rings the Closing Bell

About This Event

Sanofi (Nasdaq: SNY), a global innovative healthcare company, visits the Nasdaq MarketSite in Times Square to support the recent launch of the company’s first-in-class factor VIII replacement therapy called ALTUVIIIO™.

In honor of the occasion, Bill Sibold, Head of Specialty Care and Member of the Executive Committee at Sanofi, rings the Closing Bell.